Celldex Therapeutics Inc (CLDX) — Capital Reinvestment Ratio
Celldex Therapeutics Inc (CLDX) has a Capital Reinvestment Ratio of 0.02x as of December 2008, meaning it reinvests 0% of its operating cash flow ($1.29 Million) in capital expenditures ($26.75K). See Celldex Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Celldex Therapeutics Inc Capital Reinvestment Ratio (2006–2008)
This chart tracks Celldex Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check total reinvestment intensity of Celldex Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Celldex Therapeutics Inc (2006–2008)
Year-by-year Capital Reinvestment Ratio for Celldex Therapeutics Inc from 2006 to 2008. For live market cap and broader valuation context, see Celldex Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.07x | $18.28 Million | $1.30 Million | ▼ -79.3% |
| 2006 | 0.35x | $27.00 Million | $9.32 Million | — |